NSE: CLEAN | BSE: 543318

Expensive Performer

Download real time

794.40 -2.40 (-0.30%)

27.60% Fall from 52W High

159.8K NSE+BSE Volume

NSE 09 Oct, 2026 3:31 PM (IST)

8,443.2

Market Cap

High in industry

Beta 1Year

High Volatility

Clean Science & Technology Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for CLEAN, BSE:543318 Clean Science & Technology Ltd.

Search Inside the pdf :

Clean Science & Technology Ltd.

20 Aug 2026

794.40

-0.30%

Clean Science and Technology: Q1FY27 Result Review

Buy: Clean Science & Technology...

Recommendation Target

IDBI Capital

Q1FY27 Results: Clean Science delivered a steady performance in the quarter. Revenue and PAT increased by 11% and 5% respectively while EBITDA declined by 3% on a YoY basis. Consolidated Revenue growth was majorly led by growth in...

Clean Science & Tech.. has an average target of 918.25 from 4 brokers.

Clean Science & Technology Ltd.

02 Aug 2026

794.40

-0.30%

Near-term headwinds persist, but growth levers intact

Neutral: Clean Science & Technology...

Target

Motilal Oswal

Clean Science (CLEAN) reported a muted operating performance with an EBITDA of INR964m, down 3% YoY, while its gross margin dipped to 60.9% (from 65.5% in 1QFY26).

Promoters released all pledges in Jun 2026 qtr.

Clean Science & Technology Ltd.

15 May 2026

794.40

-0.30%

Clean Science and Technology: Q4FY26 Result Review

Hold: Clean Science & Technology...

IDBI Capital

Clean Science and Technology (Clean) reported results which were above our expectations. Standalone revenue declined by 20% YoY which was majorly owing to lower offtake of established products, pricing pressure and loss of a Chinese customer for the 4-MAP product. Sharp decline in end product pricing amid high Chinese competitive intensity have impacted realisations in FY26. Market conditions have remained very challenging amid muted demand, pricing and tariff pressures. HALS exhibited healthy performance in FY26 with revenue growth of 83% YoY which mitigated the weakness in the standalone...

Clean Science & Technology Ltd. is trading below its 30 day SMA of 823.0

Clean Science & Technology Ltd.

01 Feb 2026

794.40

-0.30%

Clean Science and Technology: Q3FY26 Result Review

Hold: Clean Science & Technology...

Recommendation Target

IDBI Capital

Clean Science and Technology (Clean) reported results which were much below our expectations. Volumes declined by 19% YoY leading to a 20% decline in standalone revenues. The decline in revenues was on account of drop in sales volumes of established products. This was owing to sharp decline in end product pricing amid high Chinese competitive intensity. Market conditions remained very challenging amid muted demand, pricing and tariff pressures. Chinese led competition has led to sharp downward pressure on Hydroquione (HQ) and Monomethyl Ether of Hydroquinone (MEHQ) prices impacting profitability. We...

Clean Science & Technology Ltd. is trading below its 30 day SMA of 823.0

Clean Science & Technology Ltd.

07 Nov 2025

794.40

-0.30%

Established products facing demand headwinds in near-term

Hold: Clean Science & Technology...

Recommendation Target

ICICI Securities Limited

Clean Science’s (CST) performance was impacted from a dip in volumes owing to demand headwinds and a Chinese customer backward integrating.

Clean Science & Technology Ltd. is trading below its 30 day SMA of 823.0

Clean Science & Technology Ltd.

07 Nov 2025

794.40

-0.30%

Clean Science and Technology: Q2FY26 Result Review

Buy: Clean Science & Technology...

Target

IDBI Capital

Clean Science and Technology (Clean) reported results which were below our expectations. Volumes declined by almost 6% YoY leading to a ~7% decline in standalone revenues. The decline in revenues was owing to drop in sales volumes of established products. This was owing to sharp decline in end product pricing amid high Chinese competitive intensity. End markets of these products for certain customers are also seeing lower demand visibility. The management mentioned that one of the prominent FMCG Chinese customer could also have backward integrated which would mean permanent loss of volumes. However,...

Clean Science & Technology Ltd. is trading above its 200 day SMA of 790.8

Clean Science & Technology Ltd.

06 Nov 2025

794.40

-0.30%

Clean Science and Technology (CLEAN IN) Q2FY26 Result Update...

Hold: Clean Science & Technology...

Target

Prabhudas Lilladhar

Clean Science & Technology Ltd. is trading below its 30 day SMA of 823.0

Clean Science & Technology Ltd.

18 Jul 2025

794.40

-0.30%

Clean Science and Technology: Q1FY26 Result Review

Buy: Clean Science & Technology...

Target

IDBI Capital

Clean Science and Technology (Clean) reported results which were in line with our expectations. The management stated that the growth is majorly led by volumes as realisations are steady. Favourable product mix led to better margin delivery at 41% as established products like MEHQ/BHA saw better growth while products with lesser salience like DCC, TBHQ and others saw weaker growth. Sales volume for HALS stood at 580 tons with total sales of Rs 240 mn in Q1FY26.The management maintained the target of 4500 tons and sales of Rs 2.1 bn for HALS in FY26 which will be driven through introduction of more...

Clean Science & Tech.. has an average target of 918.25 from 4 brokers.

Clean Science & Technology Ltd.

18 Jul 2025

794.40

-0.30%

Demand slowdown impacting growth; margins holding up well

Sell: Clean Science & Technology...

Recommendation Target

ICICI Securities Limited

Clean Science’s (CST) EBITDA grew only 5.5% YoY despite tailwinds of lower input prices, and HALS offtake. Its established products revenue has grown 8% YoY, while lower sales were due to weak demand for new products.

Clean Science & Technology Ltd. is trading above its 200 day SMA of 790.8

Clean Science & Technology Ltd.

18 Jul 2025

794.40

-0.30%

Clean Science and Technology (CLEAN IN) Q1FY26 Result Update...

Hold: Clean Science & Technology...

Target

Prabhudas Lilladhar

HALS volume reached 580tn in Q1FY26, sales volume guidance of 4,500tn for FY26 intact, current utilization at 22% Clean Science and Technology (CLEAN) reported revenue of Rs2.4bn in Q1FY26, marking an 8.4% YoY increase but a 7.9% QoQ decline. The sequential dip in topline was due to lower sales of newer products such as DCC and TBHQ. The Pharma & Agro Intermediates segment witnessed the sharpest decline, with revenue down 32% QoQ. Volume for the company's established products...

Clean Science & Technology Ltd. is trading above its 200 day SMA of 790.8

VOTE: Is Clean Science & Technology Ltd. worth buying?

252 Votes:

Buy 78.17%

Sell 11.51%

Hold 10.32%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Neutral SEE REPORTS >

pdf